Athira Pharma Inc.
ATHA
NGS
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
3.87
USD
-0.09
(-2.27%)
Optionable: Yes Market Cap: 149 M 90-day average vol: 1,022,103
Previous close: 3.96 Open: 3.93 Bid: 4.1 Ask: 4.1
52 week range
2.53 16.65
Last updated: Thursday 18th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Athira Pharma Presents Preclinical Data of Fosgonimeton (ATH-1017) and ATH-1020 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Yahoo Finance 3/2/2022
Athira Pharma's Alzheimer's therapy ATH-1017 shows promise in phase 1 study
Seeking Alpha 2/22/2022
Athira Pharma to Present Preclinical Data at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Yahoo Finance 2/22/2022
Athira Pharma Announces Publication of Phase 1 Results for Fosgonimeton (ATH-1017) in The Journal of Alzheimer's Disease
Yahoo Finance 2/22/2022
Laird Norton Trust Company, Llc Buys iShares National Muni Bond ETF, iShares Core S&P 500 ...
Yahoo Finance 2/7/2022
Athira Pharma appoints new board member
Yahoo Finance 1/31/2022
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
Yahoo Finance 1/31/2022
Athira Pharma begins dosing in phase 2 study of 1017 to treat Parkinson's disease dementia
Seeking Alpha 1/25/2022
Athira Pharma Announces Initiation of Patient Dosing in SHAPE, a Phase 2 Clinical Trial of ATH-1017 for the Treatment of Parkinson's Disease Dementia and Dementia with Lewy Bodies
Yahoo Finance 1/25/2022
Athira Pharma Provides 2022 Pipeline Outlook
Yahoo Finance 1/5/2022
Is the Options Market Predicting a Spike in Athira Pharma (ATHA) Stock?
Yahoo Finance 12/13/2021
What Kind Of Shareholders Own Athira Pharma, Inc. (NASDAQ:ATHA)?
Yahoo Finance 12/13/2021
Athira Pharma EPS beats by $0.08
Seeking Alpha 11/10/2021
Athira Pharma Reports Third Quarter 2021 Financial Results and Business Update
Yahoo Finance 11/10/2021
Athira eyes top-line data from phase 2 trial of Alzheimer's candidate in 1H 2022
Seeking Alpha 11/10/2021
Athira Pharma Presents Overview and Update from ACT-AD and LIFT-AD Trials of ATH-1017 in mild-to-moderate Alzheimer’s Disease at CTAD Conference
Yahoo Finance 11/10/2021
Athira Pharma to Present at Upcoming Investor Conferences
Yahoo Finance 11/8/2021
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!